logo

For the Inventor, By the Inventor

Hamden, CT, United States of America

Derek B Lowe

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Bayer Pharmaceuticals Corporation, Bayer Healthcare LLC, Smithkline Beecham Corporation. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Derek B Lowe. Retrieved from https://idiyas.com/inventor/derek-b-lowe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 21.4


Average Co-Inventor Count = 13.2

ph-index = 6

Forward Citations = 132(Granted Patents)


Company Filing History:

goldMedal8 out of 71 
 
Bayer Pharmaceuticals Corporation
 patents
silverMedal4 out of 789 
 
Bayer Healthcare LLC
 patents
bronzeMedal1 out of 2,198 
 
Smithkline Beecham Corporation
 patents
4. 1 out of 834,513 
Other
 patents

Years Active: 2003-2013

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 8552203 - Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation (2013-10-08),
2. 8541618 - Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation (2013-09-24),
3. 8013166 - Preparation and use of aryl alkyl acid derivatives for the treatment of obesity (2011-09-06),
4. 7968576 - Preparation and use of aryl alkyl acid derivatives for the treatment of obesity (2011-06-28),
5. 7759376 - Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity (2010-07-20),
6. 7423156 - Preparation and use of aryl alkyl acid derivatives for the treatment of obesity (2008-09-09),
7. 7358386 - Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation (2008-04-15),
8. 7112597 - Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation (2006-09-26),
9. 7091228 - Preparation and use of aryl alkyl acid derivatives for the treatment of obesity (2006-08-15),
10. 6919371 - 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists (2005-07-19),
11. 6828335 - Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation (2004-12-07),
12. 6787651 - Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-&ggr; binding agents (2004-09-07),
13. 6784167 - 17-beta-hydroxysteroid dehydrogenase-II inhibitors (2004-08-31),
14. 6660752 - 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists (2003-12-09),

Title: The Innovative Contributions of Derek B Lowe

Introduction

Derek B Lowe is a prominent inventor based in Hamden, CT (US), known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Lowe has made remarkable advancements in the treatment of various diseases.

Latest Patents

One of Lowe's latest patents focuses on indane acetic acid derivatives and their use as pharmaceutical agents. This invention relates to novel indane acetic acid derivatives that are useful in treating diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also encompasses intermediates useful in the preparation of these derivatives and methods of preparation.

Career Highlights

Throughout his career, Derek B Lowe has worked with notable companies, including Bayer Pharmaceuticals Corporation and Bayer Healthcare LLC. His work in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Lowe has collaborated with esteemed colleagues, including Mingbao Zhang and Lei Zhu, contributing to the advancement of pharmaceutical research and development.

Conclusion

Derek B Lowe's innovative work and dedication to pharmaceutical advancements have made a significant impact in the medical field. His contributions continue to pave the way for new treatments and therapies that improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…